DAFNA Capital Management LLC - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 119 filers reported holding CARA THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 1.29 and the average weighting 0.8%.

Quarter-by-quarter ownership
DAFNA Capital Management LLC ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$4,495,000
-20.8%
315,000
+20.5%
0.94%
-30.2%
Q1 2021$5,676,000
+43.5%
261,4420.0%1.35%
+14.4%
Q4 2020$3,956,000
+25.7%
261,442
+5.7%
1.18%
+15.1%
Q3 2020$3,148,000
-50.4%
247,377
-33.3%
1.02%
-44.1%
Q2 2020$6,345,000
+29.5%
371,0330.0%1.83%
-10.5%
Q1 2020$4,901,000
-7.4%
371,033
+12.9%
2.04%
+12.5%
Q4 2019$5,293,000
-23.6%
328,533
-13.3%
1.82%
-30.2%
Q3 2019$6,927,000
+57.1%
378,924
+84.8%
2.60%
+57.2%
Q2 2019$4,408,000
+56.4%
205,011
+42.8%
1.66%
+36.3%
Q1 2019$2,818,000
+50.9%
143,6110.0%1.22%
+31.0%
Q4 2018$1,867,000
-30.9%
143,611
+27.3%
0.93%
-16.4%
Q3 2018$2,702,000
+124.6%
112,811
+79.6%
1.11%
+97.2%
Q2 2018$1,203,000
+3.6%
62,811
-33.0%
0.56%
-0.4%
Q1 2018$1,161,000
+1.1%
93,8000.0%0.56%
-8.6%
Q4 2017$1,148,000
-10.6%
93,8000.0%0.62%
-22.5%
Q3 2017$1,284,000
-26.8%
93,800
-1.6%
0.80%
-46.3%
Q1 2017$1,753,000
-9.9%
95,322
-54.5%
1.48%
-13.3%
Q4 2016$1,946,000
-12.7%
209,522
-21.5%
1.71%
+10.1%
Q3 2016$2,230,000
+73.7%
267,0460.0%1.55%
+52.6%
Q2 2016$1,284,000
-22.7%
267,0460.0%1.02%
-29.0%
Q1 2016$1,661,000
-41.8%
267,046
+57.7%
1.43%
-43.7%
Q4 2015$2,855,000
+113.5%
169,331
+81.0%
2.54%
+91.8%
Q3 2015$1,337,000
-13.4%
93,574
-26.3%
1.33%
+1.7%
Q2 2015$1,543,000126,9561.30%
Other shareholders
CARA THERAPEUTICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 2,647,473$24,780,0002.96%
Chescapmanager LLC 1,160,392$10,861,0002.53%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,333,000$12,477,0001.60%
Altium Capital Management LP 193,000$1,806,0000.66%
DISCIPLINED GROWTH INVESTORS INC /MN 1,700,230$15,914,0000.44%
ALPINE WOODS CAPITAL INVESTORS, LLC 171,423$1,605,0000.22%
Lisanti Capital Growth, LLC 159,225$1,490,0000.20%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 72,529$679,0000.15%
PINNACLE ASSOCIATES LTD 705,367$6,602,0000.15%
FARALLON CAPITAL MANAGEMENT LLC 2,500,000$23,400,0000.13%
View complete list of CARA THERAPEUTICS INC shareholders